The U.S. government has purchased an additional 50 million doses of Pfizer and BioNTech’s pediatric Covid-19 vaccine, the two companies announced Thursday, as regulators are poised to green light the shot for use in children as young as five.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,